Atea Pharmaceuticals, Inc.
AVIR· Nasdaq
Released May 13, 2021, after the close
10-Q filed May 13, 2021, 43 days after period end · 0001564590-21-027644
| Metric | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|
| Revenue | $65.99M | — | — |
| Net Income | $30.71M | -$3.99M | -$2.19M |
| EPS Diluted | $0.34 | -$0.40 | — |
Atea Pharmaceuticals, Inc. · CIK 1593899 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.